Net Deals Web Search

  1. Ads

    related to: teva pharmaceutical careers chicago

Search results

  1. Results From The WOW.Com Content Network
  2. Takeda Pharmaceutical Company - Wikipedia

    en.wikipedia.org/wiki/Takeda_Pharmaceutical_Company

    Founding and initial acquisitions (1781–2010) Takeda Pharmaceuticals was founded in 1781, and was incorporated on January 29, 1925. [12] One of the firm's mainstay drugs is Actos ( pioglitazone ), a compound in the thiazolidinedione class of drugs used in the treatment of type 2 diabetes. It was launched in 1999.

  3. Teva Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Teva_Pharmaceuticals

    Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs , but other business interests include branded-drugs, active pharmaceutical ingredients (API's) and, to a lesser extent, contract manufacturing services and an out-licensing ...

  4. Baxter International - Wikipedia

    en.wikipedia.org/wiki/Baxter_International

    Baxter International was founded in 1931 by Donald Baxter, a Los Angeles -based medical doctor, as a manufacturer and distributor of intravenous therapy solutions. [4] Seeing a need for products closer to the Midwest, the company opened a manufacturing plant in Glenview, Illinois, in 1933. [4] Baxter's interest was bought out in 1935 by Ralph ...

  5. Is Teva Pharmaceutical's Growth for Real? - AOL

    www.aol.com/news/2011-11-01-is-teva...

    Teva Pharmaceutical has an intangible assets ratio of 55%. This is well above Heiserman's threshold, and you should keep a close eye on just how the company is fueling its growth.

  6. The CCC figure for Teva Pharmaceutical Industries for the trailing 12 months is 190.2. For younger, fast-growth companies, the CCC can give you valuable insight into the sustainability of that growth.

  7. Teva Pharm to stay as unified drugmaker, sees big ... - AOL

    www.aol.com/news/teva-pharm-stay-unified...

    Teva has several biosimilars - copies of high-priced drugs - and net debt is down to $16.6 billion. High debt from a failed acquisition in 2017 has held Teva back from further M&A deals, Francis said.

  1. Ads

    related to: teva pharmaceutical careers chicago